safe@home: effectiveness and cost effectiveness of telemonitoring and virtual care supported by primary care for people living with chronic disease in low socioeconomic neighbourhoods on ambulance ramping, readmission and GP clinic bloc

Not Applicable

• Conditions: heart failure; chronic obstructive pulmonary disease; diabetes; hypertension; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system; Cardiovascular - Hypertension; Respiratory - Chronic obstructive pulmonary disease; Metabolic and Endocrine - Diabetes; Public Health - Health service research

• Registration Number: ACTRN12623001125617
• Lead Sponsor: Flinders University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-10-31
• Last Update Posted: 6 November 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 744

Inclusion Criteria

•Adults 18 years and over
•Participants who have one or more chronic diseases. These include diabetes, COPD, heart failure and hypertension and at least one admission to hospital in the previous 12 months.
•Ability to use technology, i.e., smartphone (can be supported by a carer)
•Able to provide informed consent.
•For patients where English is their secondary language, an accredited interpreter will be involved.

Exclusion Criteria

•Unable to give informed consent due to cognitive impairment and no carer to support.
•Unwilling to give informed consent.
•Lives in known poor Wi-Fi neighbourhood.

Study & Design

• Study Type: Interventional
• Study Design: Not specified